| 发明名称 |
IMMUNOPOTENTIATING AGENT COMPRISING EP1 AGONIST |
| 摘要 |
An EP1 agonist has an immunopotentiating effect mediated by cytotoxic T lymphocyte activation and/or natural killer cell activation, and is thus useful for the prevention and/or treatment of cancers, microbial infectious diseases and the like.
|
| 申请公布号 |
US2011038884(A1) |
申请公布日期 |
2011.02.17 |
| 申请号 |
US20090989868 |
申请日期 |
2009.04.27 |
| 申请人 |
NATIONAL UNIVERSITY CO., HAMAMATSU UNIVER. SCHOOLOF MEDICINE |
发明人 |
TAKIGAWA MASAHIRO;SEO NAOHIRO;MARUYAMA TAKAYUKI;KANAJI TOSHIYA |
| 分类号 |
A61K39/00;A61P31/00;A61P31/04;A61P31/10;A61P31/12;A61P31/16;A61P35/00;A61P37/04 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
